PR Stories
Nighat Noureen, PhD, Awarded CPRIT Postdoctoral Training Award (Zheng Lab)
March 10, 2021
Congratulations to Nighat Noureen, PhD, a postdoctoral fellow in the lab of Greehey CCRI principal investigator, Siyuan Zheng, PhD, on recently being awarded a CPRIT fellowship training grant. Dr. Noureen joined Dr. Zheng’s lab in June 2018. Her first project was to develop a computational method to quantify telomerase activity in cancer and […]
Dr. Yogesh Gupta Delivers COVID Presentation to International Society for Stem Cell Research
February 26, 2021
On February 25, 2021, Dr. Yogesh Gupta delivered an invited talk at the International Society for Stem Cell Research COVID network meeting chaired by Hans-Willem Snoeck. MD, PhD (Columbia Univ.) and Todd McDevitt, PhD (Gladstone Inst., UCSF). At this meeting, Dr. Gupta presented his recent research on nonstructural proteins (nsps) of SARS-CoV-2. Some […]
Argonne National Laboratory: Hide and Seek: Understanding How COVID-19 Evades Detection in a Human Cell (Gupta)
November 3, 2020
BY ANDRE SALLES |OCTOBER 29, 2020 Scientists using the Advanced Photon Source have discovered new insights into the ways the SARS-CoV-2 virus camouflages itself inside the human body. Scientists around the world have been working for months to identify and develop treatments that combat SARS-CoV-2, the virus that causes COVID-19. An important part of that process […]
ECancer Interview: Prospective validation of single mouse testing by the paediatric preclinical testing consortium (Houghton)
October 24, 2020
Dr. Peter Houghton speaks to ecancer about the prospective validation of single mouse testing by the pediatric preclinical testing consortium; a study that was presented at ENA 2020 this year. Dr. Houghton initially explains the rationale behind this study and talks about how it was tested that using a single mouse for studying drug efficacy [...]Stand Up to Cancer: Alexander J. R. Bishop, DPhil to Lead One of Three Trans-Atlantic Teams to Study Hard-to-Treat Childhood Cancers
October 20, 2020
Published On: October 19, 2020 Shared by Rosanne Fohn SAN ANTONIO (Oct. 19, 2020) — Although COVID-19 has become the top health and research priority around the world, a child is still diagnosed with cancer every two minutes globally. To meet this urgent need, the Stand Up To Cancer and Cancer Research UK’s Pediatric Cancer New […]
Cardiovascular Business: Chemotherapy could be damaging children’s heart cells, leading to problems later in life (Aune)
September 30, 2020
Undergoing chemotherapy can have a negative impact on the cells responsible for repairing heart damage, according to a new study published in PLOS One. This may explain why 20% of children treated with anthracyclines go on to experience heart failure later in life. “We don’t fully understand why some children who are exposed to anthracycline therapy […]
Ignatius Lab and Team “GCCRI Goes the Extra Mile” Organizing Local Alex’s Lemonade Stand “Million Mile” Virtual Event
September 3, 2020
It’s that time of year again where we tell everyone what we do. We also remember the children with cancer and know your research will make a difference. Join us again this year for The Million Mile this September to raise awareness for Childhood Cancer Awareness Month! Last year, we raised over $3,000 for Alex’s […]
PIPETTE GAZETTE: George Parra (Libich Lab) Receives the Greehey Graduate Fellowship in Children’s Health
September 3, 2020
George Parra, a second-year student in the Biochemical Mechanisms of Medicine discipline in the Integrated Biomedical Sciences program, has received the Greehey Graduate Fellowship in Children’s Health. The Greehey Graduate Fellowship Award in Children’s Health was established by the Greehey family to support students who wish to pursue graduate scientific studies in children’s health sciences especially children’s […]
Luiz O.F. Penalva PhD Awarded CPRIT Grant to Study New Glioblastoma (GBM) Regulator
August 20, 2020
PROJECT SUMMARY Glioblastoma (GBM) is the most common and most aggressive brain tumor type among adults with a 14 months average patient survival. Despite all genomic efforts in recent years, novel therapies based on GBM common mutations and alterations have been disappointing. To build an alternative route, we have been focusing on oncogenic RNA binding […]
Alexander Pertsemlidis, PhD Co-Awarded National Science Foundation Grant.
August 20, 2020
PI: Leonidas Bleris, PhD Co-PI: Alexander Pertsemlidis, PhD (UT Dallas) (UT Health San Antonio) PROJECT SUMMARY Collaborative Research: Unraveling extracellular microRNA communication Overview: […]